NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1477058816 MD
Verify on CMS → Daniel Alape Moya, MD
Pulmonary Disease Physician in Hyannis, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
394
Medicare Part D claims · 61 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
38%
generic claims · 62% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$16.64
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Daniel Alape Moya, MD filed 394 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in Hyannis, Massachusetts, prescribing 38% generic.
- 394
- Part D claims, 2023
- 38%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Daniel Alape Moya, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
394 Top 43% higher than 57% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Daniel Alape Moya, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Alape Moya, MD?
Quality data not reportedPrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
394 73% vs specialty avg
Specialty distribution in Massachusetts
How Pulmonary Disease Physician compares to other specialties among Massachusetts providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Daniel Alape Moya, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 46 NORTH ST STE 7, Hyannis, MA, 02601, with a listed phone of (508) 775-2295. NPI 1477058816 was issued on 03/28/2018.
Medicare Part D records for calendar year 2023 show 394 prescription claims written by this provider, covering 61 Medicare beneficiaries and totaling roughly $201K in drug spend, split 62% brand-name and 38% generic by claim count.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1477058816 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 03/28/2018 |
Hospital and facility affiliations
Facilities where Daniel Alape Moya, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Daniel Alape Moya, MD is affiliated with 3 Medicare-billing facilities.
Medical Affiliates OF Cape Cod Inc
Hyannis, MA
Physicians OF Cape Cod Hospital
Hyannis, MA
Physiotherapy Associates Inc
South Dennis, MA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Alape Moya, MD. Source: openpaymentsdata.cms.gov.
Total received
$17
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Daniel Alape Moya, MD. To verify Daniel Alape Moya, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Daniel Alape Moya, MD - brand share 62.0%
Pulmonary Disease Physician average
62% brand-name claims vs 38% generic, on 394 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
394
Total Claims
$201K
Total Drug Cost
61
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 580
- Total Day Supply
- 16,832
- Brand vs Generic
- 62% brand / 38% generic
- Brand Drug Cost
- $130K
- Generic Drug Cost
- $70K
- Antibiotic Claims
- 23
Patient Demographics
- Average Patient Age
- 72.6 years
- Avg HCC Risk Score
- 1.97
- Gender Split
- 61% female / 39% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Daniel Alape Moya, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Spiriva Respimat
Spiriva Respimat
39 claims
- Trelegy Ellipta
Trelegy Ellipta
34 claims
- Montelukast Sodium
Montelukast Sodium
30 claims
- Symbicort
Symbicort
28 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
27 claims
- Ventolin Hfa
Ventolin Hfa
24 claims
- Advair Hfa
Advair Hfa
20 claims
- Azithromycin
Azithromycin
19 claims
| Drug | Claims |
|---|---|
| Spiriva Respimat Tiotropium Bromide | 39 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 34 |
| Montelukast Sodium | 30 |
| Symbicort Budesonide/Formoterol Fumarate | 28 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 27 |
| Ventolin Hfa Albuterol Sulfate | 24 |
| Advair Hfa Fluticasone Propion/Salmeterol | 20 |
| Azithromycin | 19 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 19 |
| Incruse Ellipta Umeclidinium Bromide | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Daniel Alape Moya, MD fits within the Pulmonary Disease Physician landscape nationally.
9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider
Daniel Alape Moya, MD's 394 claims are below the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Alape Moya.
Dr. Mohammad Abu Hishmeh
M.D
Springfield, MA
Dr. Anjali Ahn
M.D.
Boston, MA
Dr. Robert Aisenberg
MD
Fall River, MA
Dr. Padmastuti Akella
MD
Worcester, MA
Dr. Ala Alkhatib
MBBS
Brighton, MA
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Massachusetts medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Massachusetts
Frequently Asked Questions
What is Daniel Alape Moya, MD's specialty? ▼
Daniel Alape Moya, MD specializes in Pulmonary Disease Physician and practices in Hyannis, Massachusetts. Credentials: MD.
How much does Daniel Alape Moya, MD prescribe under Medicare Part D? ▼
In 2023, Daniel Alape Moya, MD wrote 394 Medicare Part D claims totaling $201K in drug costs for 61 beneficiaries.
Where is Daniel Alape Moya, MD located? ▼
Daniel Alape Moya, MD is located at 46 NORTH ST STE 7, Hyannis, MA, 02601. Phone: (508) 775-2295.
What is Daniel Alape Moya, MD's NPI number? ▼
Daniel Alape Moya, MD's National Provider Identifier (NPI) is 1477058816, issued on 03/28/2018.
Does Daniel Alape Moya, MD prescribe more brand-name or generic drugs? ▼
Daniel Alape Moya, MD's prescribing is 62% brand-name and 38% generic drugs by claim count, with $130K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does Daniel Alape Moya, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Daniel Alape Moya, MD's most frequently prescribed drugs include Spiriva Respimat, Trelegy Ellipta, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Alape Moya, MD accept Medicare? ▼
Daniel Alape Moya, MD appears in CMS Medicare data with 394 Part D claims and 61 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Alape Moya, MD's credentials? ▼
Daniel Alape Moya, MD's NPI is 1477058816 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.